Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN.

J Clin Psychiatry. 2005 Apr;66(4):515-20.

PMID:
15816795
2.

Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome.

Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Krönig H, Morshed S, Parveen S, Grantz H, Lombroso PJ, King RA.

Biol Psychiatry. 2005 Mar 15;57(6):667-73.

PMID:
15780855
3.

Current directions in pediatric obsessive-compulsive disorder.

Lewin AB, Storch EA, Adkins J, Murphy TK, Geffken GR.

Pediatr Ann. 2005 Feb;34(2):128-34. Review.

PMID:
15768689
4.

Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.

Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M.

J Clin Psychiatry. 2005 Mar;66(3):353-9.

PMID:
15766302
5.

Peer victimization and the development of obsessive-compulsive disorder in adolescence.

Storch EA, Heidgerken AD, Adkins JW, Cole M, Murphy TK, Geffken GR.

Depress Anxiety. 2005;21(1):41-4.

PMID:
15660378
6.

Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.

van der Wee NJ, Stevens H, Hardeman JA, Mandl RC, Denys DA, van Megen HJ, Kahn RS, Westenberg HM.

Am J Psychiatry. 2004 Dec;161(12):2201-6.

PMID:
15569890
7.

A meta-analysis of functional neuroimaging in obsessive-compulsive disorder.

Whiteside SP, Port JD, Abramowitz JS.

Psychiatry Res. 2004 Nov 15;132(1):69-79.

PMID:
15546704
9.

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.

Geller DA, Wagner KD, Emslie G, Murphy T, Carpenter DJ, Wetherhold E, Perera P, Machin A, Gardiner C.

J Am Acad Child Adolesc Psychiatry. 2004 Nov;43(11):1387-96.

PMID:
15502598
10.

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.

Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP.

J Affect Disord. 2004 Oct 15;82(2):167-74. Review.

PMID:
15488245
11.

Cognitive-behavioral therapy for children who have obsessive-compulsive disorder.

Piacentini J, Langley AK.

J Clin Psychol. 2004 Nov;60(11):1181-94.

PMID:
15389618
12.

Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.

Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ.

J Am Acad Child Adolesc Psychiatry. 2004 Sep;43(9):1146-53.

PMID:
15322418
13.

Clinicians' views on management of obsessive-compulsive disorders in children and adolescents.

Valderhaug R, Gunnar Götestam K, Larsson B.

Nord J Psychiatry. 2004;58(2):125-32.

PMID:
15204218
14.

Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature.

Stewart SE, Geller DA, Jenike M, Pauls D, Shaw D, Mullin B, Faraone SV.

Acta Psychiatr Scand. 2004 Jul;110(1):4-13. Review.

PMID:
15180774
15.

Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder.

Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR.

Am J Psychiatry. 2004 Jun;161(6):1049-56.

PMID:
15169693
16.

Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder.

Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG.

Biol Psychiatry. 2004 May 15;55(10):1041-5.

PMID:
15121489
17.

Behavioral treatment of a child with PANDAS.

Storch EA, Gerdes AC, Adkins JW, Geffken GR, Star J, Murphy T.

J Am Acad Child Adolesc Psychiatry. 2004 May;43(5):510-1. No abstract available.

PMID:
15100555
19.

Phenomenological and comorbid features associated in obsessive-compulsive disorder: influence of age of onset.

Millet B, Kochman F, Gallarda T, Krebs MO, Demonfaucon F, Barrot I, Bourdel MC, Olié JP, Loo H, Hantouche EG.

J Affect Disord. 2004 Apr;79(1-3):241-6.

PMID:
15023501
20.

Off-label indications for atypical antipsychotics: A systematic review.

Fountoulakis KN, Nimatoudis I, Iacovides A, Kaprinis G.

Ann Gen Hosp Psychiatry. 2004 Feb 18;3(1):4.

Supplemental Content

Support Center